Novavax and CPL Biologicals' Indian new facility will manufacture vaccines for the prevention of influenza.
-
Novavax and CPL Biologicals' Indian new facility will manufacture vaccines... -
The CPL Biologicals joint venture plant uses VLP vaccine techniques, which... -
Pandemic influenza strains such as H1N1 swine flu require the use of VLP...